“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Primary lateral sclerosis (PLS) is a rare neurological disorder that affects the upper motor neurons in the brain and spinal cord. It is considered a type of motor neuron disease, but unlike other motor neuron diseases such as amyotrophic lateral sclerosis (ALS), PLS does not affect the lower motor neurons that control movement in the muscles of the arms, legs, and face.
The symptoms of PLS usually begin in the legs, with stiffness, weakness, and spasticity (increased muscle tone) being the most common early signs. Over time, the symptoms may progress to involve the arms and eventually the muscles of the face and throat. People with PLS may experience difficulty with movement, balance, speech, and swallowing, but typically do not experience muscle wasting or fasciculations (muscle twitches).
PLS is a progressive disorder, but the rate of progression can vary widely from person to person. It is generally a slow-progressing disease, with most people with PLS surviving for many years after diagnosis.
There is no cure for PLS, and treatment is primarily focused on managing symptoms and maintaining function. Medications such as muscle relaxants and anti-spasticity drugs may be prescribed to help with muscle stiffness and spasms, and physical therapy and assistive devices may be used to help maintain mobility and independence. In some cases, speech and swallowing therapy may also be recommended.
The cause of PLS is not well understood, but it is thought to be a result of a combination of genetic and environmental factors. It is typically diagnosed through a combination of clinical examination, neurological testing, and imaging studies such as magnetic resonance imaging (MRI) or electromyography (EMG).
In primary lateral sclerosis, the nerve cells in the brain that control movement (upper motor neurons) slowly break down and fail over time. This makes the nerves unable to activate the motor neurons in the spinal cord, which control voluntary muscles. This loss causes movement problems, such as difficulty with balance, weakness, slowed movement and clumsiness, and problems with speech and swallowing.
The cause of PLS that begins in adulthood is unknown. In most cases, it's not an inherited disease, and it's not known why or how it begins.
Juvenile PLS is caused by mutations in a gene called ALS2.
Although researchers don't understand how this gene causes the disease, they know that the ALS2 gene gives instructions for creating a protein called alsin, which is present in motor neuron cells. When the instructions are changed in someone with juvenile PLS, the protein alsin becomes unstable and doesn't work properly, which in turn impairs normal muscle function.
Juvenile PLS is an autosomal recessive inherited disease, meaning that both parents have to be carriers of the gene to pass it to their child, even though they don't have the disease themselves.
There are no treatments to prevent, stop or reverse primary lateral sclerosis. Treatment, which focuses on relieving symptoms and preserving function, can include the following options.
Your doctor might prescribe medication to relieve symptoms:
Stretching and strengthening exercises can help maintain muscle strength, flexibility and range of motion and prevent joint immobility.
If your facial muscles are affected by PLS, speech therapy might help with communication and swallowing.
If you experience difficulty with chewing and swallowing that make eating difficult, a nutritionist can offer diet tips, nutritional supplements or special feeding methods to help maintain your body weight.
As PLS progresses, physical or occupational therapists may evaluate you periodically to determine whether you need assistive devices, such as a brace, cane, walker or wheelchair. Assistive technology devices may help with communication.